| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kv1.3 Potassium Channel | 30 | 2023 | 36 | 4.310 |
Why?
|
| Potassium Channel Blockers | 27 | 2023 | 83 | 3.520 |
Why?
|
| Arthritis, Rheumatoid | 12 | 2023 | 249 | 2.300 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 8 | 2019 | 23 | 1.950 |
Why?
|
| Autoimmune Diseases | 10 | 2023 | 248 | 1.710 |
Why?
|
| Peptides | 14 | 2023 | 798 | 1.680 |
Why?
|
| T-Lymphocytes | 26 | 2019 | 1678 | 1.600 |
Why?
|
| Cnidarian Venoms | 9 | 2015 | 10 | 1.470 |
Why?
|
| Hypersensitivity, Delayed | 9 | 2017 | 33 | 1.380 |
Why?
|
| Scorpion Venoms | 9 | 2018 | 13 | 1.350 |
Why?
|
| Rats | 32 | 2023 | 3657 | 1.300 |
Why?
|
| Potassium Channels, Voltage-Gated | 10 | 2007 | 58 | 1.290 |
Why?
|
| Immunologic Memory | 13 | 2020 | 180 | 1.210 |
Why?
|
| Ion Channels | 5 | 2018 | 187 | 1.160 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 9 | 2012 | 32 | 1.070 |
Why?
|
| Dependovirus | 2 | 2023 | 125 | 0.960 |
Why?
|
| Matrix Metalloproteinases | 2 | 2017 | 65 | 0.910 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2017 | 312 | 0.900 |
Why?
|
| Animals | 56 | 2023 | 33723 | 0.750 |
Why?
|
| Sea Anemones | 4 | 2015 | 5 | 0.720 |
Why?
|
| Rats, Inbred Lew | 16 | 2019 | 71 | 0.710 |
Why?
|
| Probiotics | 1 | 2023 | 209 | 0.690 |
Why?
|
| Cell Movement | 5 | 2016 | 838 | 0.650 |
Why?
|
| Killer Cells, Natural | 2 | 2013 | 325 | 0.620 |
Why?
|
| Cell Separation | 3 | 2007 | 237 | 0.570 |
Why?
|
| Intermediate-Conductance Calcium-Activated Potassium Channels | 5 | 2013 | 14 | 0.570 |
Why?
|
| Myoblasts, Skeletal | 1 | 2016 | 12 | 0.560 |
Why?
|
| Antirheumatic Agents | 1 | 2017 | 115 | 0.520 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 217 | 0.510 |
Why?
|
| Spinal Cord | 2 | 2007 | 301 | 0.510 |
Why?
|
| Flow Cytometry | 5 | 2016 | 810 | 0.480 |
Why?
|
| Synoviocytes | 4 | 2019 | 4 | 0.480 |
Why?
|
| Fibroblasts | 7 | 2022 | 878 | 0.470 |
Why?
|
| Potassium Channels | 7 | 2004 | 156 | 0.460 |
Why?
|
| Multiple Sclerosis | 6 | 2011 | 333 | 0.450 |
Why?
|
| Disease Models, Animal | 10 | 2018 | 4282 | 0.440 |
Why?
|
| Cells, Cultured | 11 | 2019 | 3074 | 0.440 |
Why?
|
| Models, Molecular | 9 | 2015 | 1068 | 0.440 |
Why?
|
| Th2 Cells | 1 | 2014 | 181 | 0.430 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2013 | 262 | 0.420 |
Why?
|
| Spleen | 2 | 2017 | 283 | 0.410 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2020 | 194 | 0.410 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2010 | 20 | 0.370 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1674 | 0.370 |
Why?
|
| Ovalbumin | 5 | 2017 | 316 | 0.360 |
Why?
|
| Cell Line | 13 | 2017 | 2782 | 0.360 |
Why?
|
| Mice | 23 | 2023 | 17548 | 0.360 |
Why?
|
| Adjuvants, Immunologic | 3 | 2007 | 359 | 0.350 |
Why?
|
| Synovial Membrane | 3 | 2015 | 24 | 0.350 |
Why?
|
| Interleukin-2 | 3 | 2007 | 237 | 0.340 |
Why?
|
| Patch-Clamp Techniques | 8 | 2018 | 277 | 0.340 |
Why?
|
| Arthritis, Experimental | 3 | 2019 | 14 | 0.340 |
Why?
|
| Protein Conformation | 9 | 2015 | 831 | 0.340 |
Why?
|
| Cell Differentiation | 2 | 2016 | 1935 | 0.330 |
Why?
|
| Receptors, CCR7 | 7 | 2014 | 21 | 0.330 |
Why?
|
| Lymphocyte Activation | 9 | 2014 | 680 | 0.320 |
Why?
|
| Ion Channel Gating | 4 | 2013 | 123 | 0.300 |
Why?
|
| Kv1.1 Potassium Channel | 5 | 2015 | 37 | 0.300 |
Why?
|
| Hemocyanins | 1 | 2007 | 28 | 0.290 |
Why?
|
| Freund's Adjuvant | 1 | 2007 | 26 | 0.290 |
Why?
|
| Punctures | 1 | 2007 | 55 | 0.290 |
Why?
|
| Cell Division | 3 | 2007 | 795 | 0.290 |
Why?
|
| Biomedical Technology | 1 | 2007 | 35 | 0.290 |
Why?
|
| Saphenous Vein | 1 | 2007 | 53 | 0.290 |
Why?
|
| Blood Specimen Collection | 1 | 2007 | 46 | 0.290 |
Why?
|
| Amino Acid Sequence | 8 | 2015 | 2674 | 0.280 |
Why?
|
| Cell Membrane | 3 | 2016 | 459 | 0.280 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2007 | 141 | 0.270 |
Why?
|
| Humans | 40 | 2023 | 122292 | 0.270 |
Why?
|
| Asthma | 1 | 2014 | 743 | 0.270 |
Why?
|
| Up-Regulation | 2 | 2013 | 873 | 0.260 |
Why?
|
| Calcium | 8 | 2018 | 1095 | 0.260 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2016 | 94 | 0.250 |
Why?
|
| Monocytes | 1 | 2007 | 347 | 0.250 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2004 | 11 | 0.240 |
Why?
|
| Calcium Channels | 3 | 2015 | 159 | 0.240 |
Why?
|
| Cell Adhesion | 2 | 2017 | 321 | 0.240 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 3865 | 0.230 |
Why?
|
| Mutation | 1 | 2018 | 5734 | 0.230 |
Why?
|
| Demyelinating Diseases | 1 | 2004 | 65 | 0.230 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2015 | 1679 | 0.230 |
Why?
|
| Toxins, Biological | 2 | 2015 | 71 | 0.220 |
Why?
|
| Fluoresceins | 1 | 2003 | 35 | 0.210 |
Why?
|
| Electrophysiology | 5 | 2014 | 269 | 0.210 |
Why?
|
| Neurotoxins | 3 | 2015 | 56 | 0.210 |
Why?
|
| Fluorescent Dyes | 2 | 2008 | 261 | 0.210 |
Why?
|
| Heart | 1 | 2007 | 723 | 0.200 |
Why?
|
| Immunity, Innate | 2 | 2016 | 374 | 0.200 |
Why?
|
| Terpenes | 3 | 2017 | 28 | 0.200 |
Why?
|
| Syndecan-2 | 1 | 2022 | 14 | 0.200 |
Why?
|
| Receptors, Chemokine | 3 | 2013 | 44 | 0.200 |
Why?
|
| TRPV Cation Channels | 2 | 2015 | 35 | 0.200 |
Why?
|
| Cell Proliferation | 8 | 2016 | 2313 | 0.200 |
Why?
|
| Recombinant Proteins | 3 | 2015 | 1369 | 0.190 |
Why?
|
| Pulmonary Fibrosis | 1 | 2022 | 96 | 0.180 |
Why?
|
| Pancreatitis-Associated Proteins | 2 | 2013 | 11 | 0.180 |
Why?
|
| Lung Injury | 1 | 2022 | 118 | 0.180 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2015 | 77 | 0.180 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2019 | 28 | 0.170 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 65 | 0.160 |
Why?
|
| Proteins | 3 | 2014 | 1043 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2006 | 783 | 0.160 |
Why?
|
| Brain | 2 | 2007 | 2937 | 0.160 |
Why?
|
| Immunosuppressive Agents | 3 | 2012 | 645 | 0.160 |
Why?
|
| Interleukin-10 | 2 | 2023 | 170 | 0.150 |
Why?
|
| Phenotype | 5 | 2018 | 4150 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2017 | 323 | 0.150 |
Why?
|
| Gene Editing | 1 | 2020 | 177 | 0.150 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2018 | 45 | 0.150 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 112 | 0.150 |
Why?
|
| Emulsions | 2 | 2007 | 64 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2014 | 287 | 0.140 |
Why?
|
| Arthritis | 2 | 2015 | 80 | 0.140 |
Why?
|
| Integrin beta1 | 1 | 2017 | 54 | 0.140 |
Why?
|
| Testicular Diseases | 1 | 2016 | 11 | 0.140 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2015 | 337 | 0.140 |
Why?
|
| Cell Fusion | 1 | 2016 | 43 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2017 | 79 | 0.140 |
Why?
|
| Intracellular Space | 1 | 2016 | 48 | 0.140 |
Why?
|
| Inflammation | 2 | 2023 | 1392 | 0.140 |
Why?
|
| Female | 22 | 2019 | 64882 | 0.140 |
Why?
|
| Kinetics | 3 | 2015 | 1315 | 0.130 |
Why?
|
| Antigens | 3 | 2007 | 156 | 0.130 |
Why?
|
| Peptide Fragments | 3 | 2015 | 745 | 0.130 |
Why?
|
| Genetic Vectors | 1 | 2020 | 969 | 0.130 |
Why?
|
| Memory | 1 | 2019 | 357 | 0.130 |
Why?
|
| Learning | 1 | 2019 | 358 | 0.130 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2016 | 99 | 0.130 |
Why?
|
| Adoptive Transfer | 3 | 2007 | 237 | 0.130 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 668 | 0.130 |
Why?
|
| Liver | 1 | 2023 | 1851 | 0.130 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 565 | 0.130 |
Why?
|
| Time Factors | 4 | 2007 | 6181 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 352 | 0.130 |
Why?
|
| Disulfides | 2 | 2005 | 78 | 0.120 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2015 | 2 | 0.120 |
Why?
|
| Myelin Basic Protein | 3 | 2004 | 69 | 0.120 |
Why?
|
| Myotonic Dystrophy | 1 | 2016 | 146 | 0.120 |
Why?
|
| Calcium Signaling | 2 | 2014 | 241 | 0.120 |
Why?
|
| Antibody Formation | 1 | 2015 | 255 | 0.120 |
Why?
|
| Cystic Fibrosis | 1 | 2018 | 261 | 0.120 |
Why?
|
| Allergens | 1 | 2017 | 244 | 0.120 |
Why?
|
| Protein Stability | 2 | 2014 | 166 | 0.120 |
Why?
|
| Mutant Proteins | 1 | 2015 | 111 | 0.120 |
Why?
|
| Injections, Subcutaneous | 3 | 2017 | 126 | 0.120 |
Why?
|
| Gene Expression Regulation | 4 | 2022 | 2534 | 0.120 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2014 | 23 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2016 | 461 | 0.120 |
Why?
|
| Interleukin-5 | 1 | 2014 | 42 | 0.110 |
Why?
|
| Rats, Inbred F344 | 1 | 2014 | 106 | 0.110 |
Why?
|
| Protein Engineering | 2 | 2011 | 74 | 0.110 |
Why?
|
| Drug Design | 1 | 2015 | 148 | 0.110 |
Why?
|
| Antioxidants | 1 | 2016 | 337 | 0.110 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2013 | 10 | 0.110 |
Why?
|
| Nanoparticles | 1 | 2016 | 227 | 0.110 |
Why?
|
| Interleukin-4 | 1 | 2014 | 139 | 0.110 |
Why?
|
| Helminths | 1 | 2014 | 42 | 0.110 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2014 | 157 | 0.110 |
Why?
|
| Interleukin-13 | 1 | 2014 | 95 | 0.110 |
Why?
|
| Cell Degranulation | 1 | 2013 | 29 | 0.110 |
Why?
|
| K562 Cells | 1 | 2013 | 95 | 0.110 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 618 | 0.110 |
Why?
|
| Cytokines | 4 | 2023 | 1272 | 0.110 |
Why?
|
| Antibodies, Bacterial | 1 | 2015 | 382 | 0.110 |
Why?
|
| Neural Conduction | 2 | 2004 | 91 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2016 | 311 | 0.110 |
Why?
|
| Interleukin-12 | 1 | 2013 | 118 | 0.110 |
Why?
|
| Immune Tolerance | 1 | 2014 | 145 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2015 | 768 | 0.110 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 201 | 0.110 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2015 | 166 | 0.110 |
Why?
|
| Pichia | 1 | 2012 | 46 | 0.110 |
Why?
|
| Interleukin-15 | 1 | 2013 | 95 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 303 | 0.100 |
Why?
|
| Pyrazoles | 2 | 2013 | 300 | 0.100 |
Why?
|
| Thioredoxins | 1 | 2012 | 23 | 0.100 |
Why?
|
| Obesity | 1 | 2023 | 2083 | 0.100 |
Why?
|
| Synovial Fluid | 1 | 2011 | 15 | 0.100 |
Why?
|
| Rheumatic Fever | 1 | 2011 | 18 | 0.100 |
Why?
|
| Young Adult | 2 | 2017 | 8759 | 0.100 |
Why?
|
| Shaker Superfamily of Potassium Channels | 1 | 2011 | 27 | 0.100 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 621 | 0.100 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2010 | 15 | 0.090 |
Why?
|
| Acrylic Resins | 1 | 2010 | 25 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2013 | 606 | 0.090 |
Why?
|
| Guinea Pigs | 4 | 2003 | 169 | 0.090 |
Why?
|
| Middle Aged | 6 | 2017 | 25636 | 0.090 |
Why?
|
| Rats, Wistar | 2 | 2017 | 356 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2011 | 176 | 0.090 |
Why?
|
| Binding, Competitive | 2 | 2012 | 179 | 0.090 |
Why?
|
| Neoplasms | 2 | 2014 | 2753 | 0.080 |
Why?
|
| Adult | 6 | 2017 | 28730 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2014 | 658 | 0.080 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2007 | 124 | 0.080 |
Why?
|
| Ear, External | 1 | 2008 | 22 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2023 | 3770 | 0.080 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2008 | 38 | 0.080 |
Why?
|
| Shab Potassium Channels | 1 | 2007 | 2 | 0.080 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2007 | 5 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 1 | 2008 | 119 | 0.080 |
Why?
|
| NAV1.8 Voltage-Gated Sodium Channel | 1 | 2007 | 5 | 0.080 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2007 | 3 | 0.080 |
Why?
|
| Concanavalin A | 1 | 2007 | 15 | 0.080 |
Why?
|
| HEK293 Cells | 3 | 2019 | 741 | 0.070 |
Why?
|
| Mitogens | 1 | 2007 | 30 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2012 | 382 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 751 | 0.070 |
Why?
|
| Blood Cells | 1 | 2007 | 50 | 0.070 |
Why?
|
| Protein Structure, Secondary | 2 | 2005 | 238 | 0.070 |
Why?
|
| Injections, Intradermal | 1 | 2007 | 31 | 0.070 |
Why?
|
| Rats, Inbred Strains | 1 | 2007 | 229 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2016 | 1213 | 0.070 |
Why?
|
| Dermatitis | 1 | 2007 | 25 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3050 | 0.070 |
Why?
|
| Sodium Channels | 1 | 2007 | 109 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2022 | 493 | 0.070 |
Why?
|
| Calcium Channel Blockers | 2 | 2004 | 113 | 0.070 |
Why?
|
| Immunization | 2 | 2020 | 302 | 0.070 |
Why?
|
| Structure-Activity Relationship | 3 | 2015 | 570 | 0.070 |
Why?
|
| Optic Nerve | 2 | 2004 | 117 | 0.060 |
Why?
|
| Protein Binding | 3 | 2015 | 1732 | 0.060 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2005 | 12 | 0.060 |
Why?
|
| Male | 10 | 2019 | 59517 | 0.060 |
Why?
|
| RNA Interference | 2 | 2018 | 496 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3448 | 0.060 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2004 | 12 | 0.060 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2004 | 13 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 663 | 0.060 |
Why?
|
| Static Electricity | 1 | 2004 | 40 | 0.060 |
Why?
|
| Synaptosomes | 1 | 2004 | 31 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2005 | 170 | 0.060 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 49 | 0.060 |
Why?
|
| Furocoumarins | 1 | 2004 | 3 | 0.060 |
Why?
|
| Elapid Venoms | 1 | 2004 | 8 | 0.060 |
Why?
|
| Lymphocytes | 2 | 2004 | 403 | 0.060 |
Why?
|
| Action Potentials | 2 | 2004 | 499 | 0.060 |
Why?
|
| Gene Expression | 2 | 2020 | 1579 | 0.060 |
Why?
|
| Myelin Sheath | 1 | 2004 | 133 | 0.050 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2015 | 102 | 0.050 |
Why?
|
| Magnesium | 1 | 2023 | 121 | 0.050 |
Why?
|
| Biotin | 1 | 2003 | 41 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2007 | 1166 | 0.050 |
Why?
|
| Th17 Cells | 1 | 2023 | 91 | 0.050 |
Why?
|
| Anti-Citrullinated Protein Antibodies | 1 | 2022 | 4 | 0.050 |
Why?
|
| Citrullination | 1 | 2022 | 6 | 0.050 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2022 | 10 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2003 | 469 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2003 | 151 | 0.050 |
Why?
|
| Sp1 Transcription Factor | 1 | 2022 | 43 | 0.050 |
Why?
|
| Bleomycin | 1 | 2022 | 150 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 212 | 0.050 |
Why?
|
| Binding Sites | 2 | 2015 | 1292 | 0.050 |
Why?
|
| Collagen | 2 | 2015 | 311 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 369 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 1592 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2004 | 1007 | 0.040 |
Why?
|
| COS Cells | 2 | 2012 | 273 | 0.040 |
Why?
|
| Gene Order | 1 | 2020 | 78 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2003 | 678 | 0.040 |
Why?
|
| Amino Acids | 1 | 2003 | 660 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 343 | 0.040 |
Why?
|
| Scorpions | 2 | 2012 | 4 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2020 | 333 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 2817 | 0.040 |
Why?
|
| Indenes | 1 | 2018 | 10 | 0.040 |
Why?
|
| Transgenes | 1 | 2020 | 330 | 0.040 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2018 | 24 | 0.040 |
Why?
|
| Furans | 1 | 2018 | 27 | 0.040 |
Why?
|
| Sulfones | 1 | 2018 | 66 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2020 | 250 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2018 | 99 | 0.040 |
Why?
|
| Language Development Disorders | 1 | 2019 | 171 | 0.040 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2018 | 196 | 0.040 |
Why?
|
| Isotope Labeling | 2 | 2012 | 102 | 0.040 |
Why?
|
| Dogs | 1 | 2018 | 761 | 0.040 |
Why?
|
| Arteries | 1 | 2018 | 219 | 0.040 |
Why?
|
| Aging | 1 | 2004 | 1165 | 0.040 |
Why?
|
| Inflammasomes | 1 | 2018 | 149 | 0.030 |
Why?
|
| Nanoconjugates | 1 | 2016 | 2 | 0.030 |
Why?
|
| Nanocapsules | 1 | 2016 | 7 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2018 | 258 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 142 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2016 | 17 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2016 | 48 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2022 | 2440 | 0.030 |
Why?
|
| Cannabidiol | 1 | 2015 | 21 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 70 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 351 | 0.030 |
Why?
|
| Cannabinoids | 1 | 2015 | 31 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2015 | 119 | 0.030 |
Why?
|
| Drosophila | 1 | 2019 | 765 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2015 | 222 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2016 | 2826 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 1476 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 847 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2014 | 164 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 1104 | 0.030 |
Why?
|
| Indoles | 1 | 2015 | 177 | 0.030 |
Why?
|
| Metabolomics | 1 | 2016 | 389 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 479 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2013 | 140 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2014 | 654 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 408 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2018 | 4510 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 2005 | 968 | 0.030 |
Why?
|
| Saimiri | 1 | 2012 | 11 | 0.030 |
Why?
|
| Absorption | 1 | 2012 | 52 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 2012 | 70 | 0.030 |
Why?
|
| Cancer Vaccines | 1 | 2014 | 187 | 0.030 |
Why?
|
| Nitrogen Isotopes | 1 | 2012 | 54 | 0.030 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2012 | 43 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 387 | 0.030 |
Why?
|
| Amides | 1 | 2012 | 82 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2012 | 85 | 0.030 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2012 | 43 | 0.030 |
Why?
|
| Enzyme Precursors | 1 | 2011 | 22 | 0.020 |
Why?
|
| Gelatinases | 1 | 2011 | 14 | 0.020 |
Why?
|
| Phylogeny | 1 | 2014 | 681 | 0.020 |
Why?
|
| Protein Folding | 1 | 2012 | 214 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2011 | 3229 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 668 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2011 | 43 | 0.020 |
Why?
|
| Sunlight | 1 | 2011 | 22 | 0.020 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2011 | 22 | 0.020 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2011 | 13 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 2933 | 0.020 |
Why?
|
| Cholecalciferol | 1 | 2011 | 22 | 0.020 |
Why?
|
| CTLA-4 Antigen | 1 | 2011 | 50 | 0.020 |
Why?
|
| Glycosylation | 1 | 2011 | 110 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2011 | 209 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 317 | 0.020 |
Why?
|
| Vaccination | 1 | 2015 | 927 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 413 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2013 | 826 | 0.020 |
Why?
|
| Haplotypes | 1 | 2011 | 510 | 0.020 |
Why?
|
| Chlamydia trachomatis | 1 | 2008 | 21 | 0.020 |
Why?
|
| Xanthenes | 1 | 2008 | 7 | 0.020 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2011 | 252 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2011 | 419 | 0.020 |
Why?
|
| Chlamydia Infections | 1 | 2008 | 45 | 0.020 |
Why?
|
| Orthomyxoviridae | 1 | 2008 | 50 | 0.020 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2008 | 56 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 2008 | 35 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 702 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 4366 | 0.020 |
Why?
|
| Homeostasis | 1 | 2011 | 680 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2012 | 978 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2008 | 376 | 0.020 |
Why?
|
| Aged | 2 | 2016 | 18783 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 1575 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 3292 | 0.020 |
Why?
|
| Skin | 1 | 2008 | 503 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2011 | 1462 | 0.010 |
Why?
|
| Cnidaria | 1 | 2003 | 2 | 0.010 |
Why?
|
| CD3 Complex | 1 | 2003 | 84 | 0.010 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2003 | 47 | 0.010 |
Why?
|
| Thymidine | 1 | 2001 | 55 | 0.010 |
Why?
|
| Tritium | 1 | 2001 | 174 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 330 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1710 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 4643 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2001 | 24 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2001 | 76 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 6289 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2003 | 398 | 0.010 |
Why?
|
| Child | 1 | 2019 | 24063 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 671 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 9901 | 0.010 |
Why?
|